ArticleEndocrine2025
Estimated fracture risk in osteopenic patients with primary hyperparathyroidism.
Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile osteoporosis in primary hyperparathyroidism (PHPT) is widely studied, PHPT patients with osteopenia remain less characterized. This study aimed to evaluate the prevalence, biochemical features, and estimated fracture risk of osteopenic PHPT patients in a real-life cohort.
methodsWe retrospectively analyzed a consecutive series of PHPT patients with available densitometric data at three sites. Postmenopausal women and men over 50 years old with PHPT and osteopenia were selected. FRAX scores were used to estimate fracture risk, and subgroup analyses were conducted based on sex, age, and PHPT clinical presentation.
resultsOne hundred out of 439 PHPT patients (22.8%) were osteopenic. As compared to osteopenic women, osteopenic men were older (p = 0.03), had higher BMD at the spine and femoral neck (p = 0.007 and p = 0.006, respectively), and more frequent occurrence of nephrolithiasis (p = 0.046). Osteopenic patients older than 65 years had worst FRAX scores and higher prevalence of comorbidities, as type 2 diabetes and hypertension, than their younger counterparts (both p < 0.001). FRAX scores of osteopenic PHPT patients were not different according to their clinical classification of PHPT.
conclusionsPatients with osteopenia account for about one fifth of our whole series and two thirds of them met surgical indication according to latest international guidelines. Neither densitometric data nor estimated fracture risk differed between osteopenic PHPT patients meeting or not surgical criteria.
Indexed as
Identifiers
40928688What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.